CAS: 1628614-50-5
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
XMD-17-51 REF: TM-T22460CAS: 1628614-50-5 | 98% | 907.00 €~2,337.00 € | Wed 19 Feb 25 | |
5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one REF: 3D-DQC61450CAS: 1628614-50-5 | Min. 95% | - - - | Discontinued product |
XMD-17-51
CAS:1628614-50-5
XMD-17-51 is a potent and highly selective NUAK1 inhibitor.
Formula:
C21H24N8O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
404.47
Ref: TM-T22460
25mg | 1,410.00 € | ||
50mg | 1,851.00 € | ||
100mg | 2,337.00 € |
Estimated delivery in United States, on Wednesday 19 Feb 2025
5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
CAS:1628614-50-5
5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one is a small molecule that binds to the Nmethyl D aspartate receptor (NMDAR). It …
Formula:
C21H24N8O
Purity:
Min. 95%
Molecular weight:
404.5 g/mol
Ref: 3D-DQC61450
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |